Success Metrics

Clinical Success Rate
50.0%

Based on 2 completed trials

Completion Rate
50%(2/4)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Terminated
2(50%)

Phase Distribution

Ph phase_3
2
50%
Ph phase_1
1
25%
Ph not_applicable
1
25%

Phase Distribution

1

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 3Large-scale testing
2(50.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(2)
Terminated(2)

Detailed Status

Completed2
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
50.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (25.0%)
Phase 32 (50.0%)
N/A1 (25.0%)

Trials by Status

completed250%
terminated250%

Recent Activity

0 active trials
Showing 4 of 4
completedphase_3

Zometa Study in Pediatric Acute Lymphoblastic Leukemia

NCT01656512
completednot_applicable

Calcium and Vitamin D Supplementation Decreases Incidence of Stress Fractures in Female Navy Recruits

NCT00476346
terminatedphase_3

Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I

NCT00171925
terminatedphase_1

Bone Mineral Density, Body Composition and Growth Following Severe Burn Injury

NCT00285090

Clinical Trials (4)

Showing 4 of 4 trials
NCT01656512Phase 3

Zometa Study in Pediatric Acute Lymphoblastic Leukemia

Completed
NCT00476346Not Applicable

Calcium and Vitamin D Supplementation Decreases Incidence of Stress Fractures in Female Navy Recruits

Completed
NCT00171925Phase 3

Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I

Terminated
NCT00285090Phase 1

Bone Mineral Density, Body Composition and Growth Following Severe Burn Injury

Terminated

All 4 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
4